Cetnine PFS 0.25mg Injection

generic_icon
Rs.1558for 1 vial(s) (0.5 ml Injection each)
1
Unfortunately, we don't have any more items in stock
Report Error

Composition FOR Cetnine PFS 0.25mg Injection

Cetrorelix(0.25mg)

food interaction for Cetnine PFS Injection

alcohol interaction for Cetnine PFS Injection

pregnancy interaction for Cetnine PFS Injection

lactation interaction for Cetnine PFS Injection

food
alcohol
pregnancy
lactation
No interaction found/established
Caution is advised when consuming alcohol with Cetnine PFS 0.25mg Injection. Please consult your doctor.
CAUTION
Cetnine PFS 0.25mg Injection is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
UNSAFE
Cetnine PFS 0.25mg Injection is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
UNSAFE

SALT INFORMATION FOR Cetnine PFS 0.25mg Injection

Cetrorelix(0.25mg)

Cetnine pfs injection uses

{med_name} is used in the treatment of female infertility.

How cetnine pfs injection works

In females undergoing treatment for infertility, sometimes premature ovulation can lead to the release of eggs which are not ready for fertilisation. Cetnine PFS 0.25mg Injection blocks the action of a natural hormone and prevents premature release of the eggs from the ovary.

Common side effects of cetnine pfs injection

Nausea, Ovarian hyperstimulation syndrome, Injection site reactions (pain, swelling, redness), Itching, Irritation, Vomiting, Lower abdominal pain

SUBSTITUTES FOR Cetnine PFS Injection

23 Substitutes
23 Substitutes
Sorted By
RelevancePrice
  • Cetrolix 0.25mg Injection
    (1 Injection in vial)
    Intas Pharmaceuticals Ltd
    Rs. 1389/Injection
    Injection
    Rs. 1457.50
    save 11% more per Injection
  • Ciscure 0.25mg Injection
    (2 ml Injection in vial)
    Emcure Pharmaceuticals Ltd
    Rs. 902.50/ml of Injection
    generic_icon
    Rs. 1862
    save 42% more per ml of Injection
  • Ovucet 0.25mg Injection
    (1 Injection in vial)
    Zydus Cadila
    Rs. 1803/Injection
    Injection
    Rs. 1859.75
    pay 16% more per Injection
  • Setrosil 0.25mg Injection
    (1 Injection in vial)
    Serum Institute Of India Ltd
    Rs. 1093/Injection
    Injection
    Rs. 1127.40
    save 30% more per Injection
  • Asporelix 0.25mg Injection
    (1 Injection in vial)
    Bharat Serums & Vaccines Ltd
    Rs. 1550/Injection
    Injection
    Rs. 1598.30
    save 1% more per Injection

Expert advice FOR Cetnine PFS Injection

  • Cetrorelix helps prevent premature ovulation in women undergoing assisted reproduction treatments such as IVF.
  • It is given as an injection under the skin (subcutaneously), preferably of the upper leg.
  • Inform your doctor immediately if you get very dizzy, faint, vomit, or have diarrhea while using this medicine. These could be symptoms of ovarian hyperstimulation syndrome (OHSS).
  • Do not use this medicine if you are already pregnant or breastfeeding.

Frequently asked questions FOR Cetnine PFS 0.25mg Injection

Cetrorelix

Q. What is Cetnine PFS 0.25mg Injection and for what it is used for?
Cetnine PFS 0.25mg Injection is an injectable preparation, which contains the active substance Ganirelix. It is used in women undergoing certain fertility treatments. It acts by blocking the release of luteinizing hormone (LH) thus preventing eggs from being released too early and gives the eggs time to grow properly. It is usually used in combination with other medicines.
Q. How and in what dose can it be used?
It is given as an injection, only at the hospital or clinic by the medical healthcare professional. The patient may be monitored regularly for the follicular development. The treatment duration depends on the ovarian response of the patient.
Q. What may be the possible side effects associated with it?
The most common side effect is local site reaction (redness of skin with or without swelling). You may also feel a headache or nausea. However, these effects are temporary, if these persist consult with your doctor. In addition, conditions like ovarian hyperstimulation syndrome (OHSS), and multiple births or birth defect, may also be associated with the use of this medicine.

Content on this page was last updated on 29 November, 2023, by Dr. Varun Gupta (MD Pharmacology)